NL192778B - Farmaceutisch preparaat dat anti-anoxie-werking heeft en arteriosclerotische beschadigingen remt. - Google Patents

Farmaceutisch preparaat dat anti-anoxie-werking heeft en arteriosclerotische beschadigingen remt.

Info

Publication number
NL192778B
NL192778B NL8400488A NL8400488A NL192778B NL 192778 B NL192778 B NL 192778B NL 8400488 A NL8400488 A NL 8400488A NL 8400488 A NL8400488 A NL 8400488A NL 192778 B NL192778 B NL 192778B
Authority
NL
Netherlands
Prior art keywords
inhibits
pharmaceutical preparation
anoxic
action
arteriosclerotic
Prior art date
Application number
NL8400488A
Other languages
English (en)
Other versions
NL8400488A (nl
NL192778C (nl
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of NL8400488A publication Critical patent/NL8400488A/nl
Publication of NL192778B publication Critical patent/NL192778B/nl
Application granted granted Critical
Publication of NL192778C publication Critical patent/NL192778C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NL8400488A 1983-02-16 1984-02-15 Farmaceutisch preparaat dat anti-anoxie-werking heeft en arteriosclerotische beschadigingen remt. NL192778C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH85883 1983-02-16
CH858/83A CH655005A5 (it) 1983-02-16 1983-02-16 Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Publications (3)

Publication Number Publication Date
NL8400488A NL8400488A (nl) 1984-09-17
NL192778B true NL192778B (nl) 1997-10-01
NL192778C NL192778C (nl) 1998-02-03

Family

ID=4196830

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8400488A NL192778C (nl) 1983-02-16 1984-02-15 Farmaceutisch preparaat dat anti-anoxie-werking heeft en arteriosclerotische beschadigingen remt.

Country Status (11)

Country Link
US (1) US4599232A (nl)
JP (1) JPS59186914A (nl)
BE (1) BE898918A (nl)
CH (1) CH655005A5 (nl)
DE (1) DE3405581A1 (nl)
DK (1) DK165167C (nl)
FR (1) FR2543827B1 (nl)
GB (1) GB2137088B (nl)
IT (1) IT1170235B (nl)
NL (1) NL192778C (nl)
SE (1) SE457143B (nl)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209519B (it) * 1984-04-10 1989-08-30 Poli Ind Chimica Spa Composti ad attivita'cardiotrofica.
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
CH670763A5 (nl) * 1985-08-02 1989-07-14 Seuref Ag
CH666183A5 (it) * 1985-08-06 1988-07-15 Seuref Ag Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock
SE8703321D0 (sv) * 1987-08-27 1987-08-27 Sockerbolaget Ab Kostforsterkning
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
GB8907276D0 (en) * 1989-03-31 1989-05-17 Therapy Advisory Services Limi Health supplement
AT393954B (de) * 1990-02-28 1992-01-10 Bock Orthopaed Ind Verfahren und vorrichtung zur bestimmung von gebrauchseigenschaften eines prothesenschaftes
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
ATE271614T1 (de) * 1992-05-28 2004-08-15 Ct For Molecular Biology And M Quinone-derivate zur verbesserung der zellulare bioenergie
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
CA2284738C (en) * 1997-03-27 2008-12-23 Michael J. Sole Nutritional composition for improvements in cell energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
AU3221599A (en) 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US7371415B1 (en) 1998-04-03 2008-05-13 The Daily Wellness Company Method and composition for improving sexual fitness
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US20070072927A1 (en) * 1999-09-23 2007-03-29 Vita Joseph A Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU7828200A (en) 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6335361B1 (en) 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6740338B1 (en) 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
JP2003529347A (ja) * 2000-01-25 2003-10-07 ジュヴェノン インコーポレイテッド 高齢ペット用の栄養補給食品
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
US6441050B1 (en) 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
US6579866B2 (en) 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US7754205B2 (en) * 2001-05-10 2010-07-13 Kaneka Corporation Composition for transmucosal administration containing conenzyme Q as the active ingredient
EP1407782A4 (en) * 2001-06-28 2004-10-20 Takeda Chemical Industries Ltd DRUGS FOR THE PREVENTION / TREATMENT OF FUNCTIONAL ORGAN DISORDERS AND ORGAN DYSFUNCTION
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
AU2004277951B2 (en) * 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101022793B (zh) * 2004-06-29 2011-05-11 美国益力斯林公司 用以促进新陈代谢和降低活性氧水平的食品组合物
HUE033304T2 (en) 2005-06-01 2017-11-28 Bioelectron Tech Corp Redoxactive therapeutic agents for the treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
HUE052377T2 (hu) * 2005-09-15 2021-04-28 Ptc Therapeutics Inc Redox-aktív terápiás szerek farokvariánsai mitokondriális betegségek és egyéb állapotok kezelésére és az energia-biomarkerek modulálására
WO2007084839A2 (en) * 2006-01-13 2007-07-26 Elixirin Corporation Dietary methods and compositions for enhancing metabolism and reducting reactive oxygen species
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US7615324B2 (en) * 2007-03-14 2009-11-10 Fujifilm Corporation Photosensitive composition, and cured relief pattern production method and semiconductor device using the same
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
ES2306610B1 (es) * 2007-04-16 2009-09-11 Universidad De Sevilla Uso de la l-carnitina para el tratamiento de la hipertension arterial.
WO2009001786A1 (ja) * 2007-06-22 2008-12-31 Kaneka Corporation 生理活性物質含有組成物
TW200916090A (en) * 2007-06-22 2009-04-16 Kaneka Corp Composition comprising coenzyme Q10
JP5364580B2 (ja) * 2007-08-22 2013-12-11 株式会社カネカ 還元型補酵素ｑ１０の製造方法、ならびに、その安定化方法
CN101951930A (zh) * 2008-02-19 2011-01-19 阿奈斯特药品株式会社 对身体功能的恢复有用的口服或经肠组合物
JP2012502064A (ja) 2008-09-10 2012-01-26 エジソン ファーマシューティカルズ， インコーポレイテッド 酸化還元活性治療剤を用いての広汎性発達障害の処置
JP6905527B2 (ja) 2015-12-17 2021-07-21 ピーティーシー セラピューティクス， インコーポレイテッド 酸化ストレス障害を処置するためのフルオロアルキル、フルオロアルコキシ、フェノキシ、ヘテロアリールオキシ、アルコキシ、およびアミノ１，４−ベンゾキノン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene

Also Published As

Publication number Publication date
DK165167B (da) 1992-10-19
IT1170235B (it) 1987-06-03
US4599232A (en) 1986-07-08
SE8400851D0 (sv) 1984-02-16
NL8400488A (nl) 1984-09-17
DK165167C (da) 1993-03-01
FR2543827B1 (fr) 1987-06-12
BE898918A (nl) 1984-08-16
DK72284D0 (da) 1984-02-16
DE3405581A1 (de) 1984-10-18
GB8403668D0 (en) 1984-03-14
GB2137088B (en) 1986-02-05
DE3405581C2 (nl) 1992-10-22
SE8400851L (sv) 1984-08-17
JPS59186914A (ja) 1984-10-23
CH655005A5 (it) 1986-03-27
DK72284A (da) 1984-08-17
FR2543827A1 (fr) 1984-10-12
IT8323559A0 (it) 1983-10-31
SE457143B (sv) 1988-12-05
JPH027572B2 (nl) 1990-02-19
NL192778C (nl) 1998-02-03
GB2137088A (en) 1984-10-03

Similar Documents

Publication Publication Date Title
NL192778B (nl) Farmaceutisch preparaat dat anti-anoxie-werking heeft en arteriosclerotische beschadigingen remt.
DK345684D0 (da) Analgetisk middel
FR2547727B1 (fr) Compositions pharmaceutiques
FI881676A0 (fi) Anordning foer upphaengning och behandling av skivorgan.
FI841346A (fi) Tio2 med fluoridjoner innehaollande oeverdrag.
DK475684D0 (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
IT1183060B (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
DK321088A (da) Thiazolidindionderivater
DE3482223D1 (de) Plattenspieler.
FI880721A0 (fi) Vattenbestaendigt silikatkonstruktionsmaterial och foerfarande foer framstaellning daerav.
IT1233001B (it) Assieme di elementi accoppiabili per gioco e mezzi di imballaggio dello stesso.
IT8322028V0 (it) Giunto per mobili.
FI843183A (fi) Flerstegskokningsfoerfarande foer cellulosa med en diskontinuerlig kokare.
DK499784D0 (da) Cephemderivater.
FI853199L (fi) Farmaceutiska sammansaettningar med tumoermotverkande effekt och foerfarande foer framstaellning av dessa.
NO882764D0 (no) Preparater for overflatebehandling.
DK114884A (da) Farmaceutisk iodoforpraeparat samt fremgangsmaade til fremstilling deraf
PT87482A (pt) Staging
FR2619009B1 (fr) Agent anti-hyperlipemique
FI843328A (fi) Foerfarande foer framstaellning av staol med laog kolhalt under reglering av kolets aendpunkt och smaelttemperatur.
DE3474664D1 (de) Imidazoquinoline derivatives
DE3761240D1 (de) Antihypoxisches mittel.
IT1206705B (it) Preparazioni. 1-fenossi-3-idrossiindolil-alchilammino-3-propanoli e loro
FR2616660B1 (fr) Agent antiepileptique
IT8322029V0 (it) Giunto per mobili.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20040215